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A 92-kD trans glutaminase (TGase K), expressed in human 
cultured keratinocytes and stratum corneum, catalyzes a criti-
cal step in the formation of the cornified envelope of terminal 
differentiation. A rabbit polyclonal antibody to TGase K was 
us.ed to isolate overlapping eDNA clones from a human ker-
atl110cyte eDNA expression library. The eDNA clones were 
sequenced and unequivocally identified as TGase K by com-
parison to the N -terminal amino acid sequences of two cyano-
gen bromide fragments from the purified enzyme. The 
mRN A for T gase K is expressed in cuI tured keratinocytes but 
not in A431 squamous carcinoma cells, in fibroblasts, or in 
other non-epithelial tissues and cells. Although TGase K 
pr?tein expression is limited to the upper layers of normal 
epidermis, the mRNA is generally present throughout the 
T erminal differentiation of epidermal keratinoeytes in-volves formation of a covalently crosslinked protein layer beneath the cell membrane. This step is cata-lyzed by the enzyme transglutaminase, which links adjacent proteins by formation of the N-(y-gluta-
myl)-lysine isopeptide bond [1]. A keratinocyte transglutaminase , 
also referred to as type I transglutaminase, or TGase K, has been 
Identified in cultured epidermal keratinocytes and related cell types 
as a 92~kD protein [2 - 4]. It is largely membrane bound and is found 
rrllnanly in stratified squamous epithelia, where its expression is 
Imlted to the more differentiated cell layers [2,4,5]. A mRNA from 
rabbit tracheal cells has been described that contains sequence ho-
mology to other more extensively described transglutaminases [6] . 
epidermis, suggesting the possibility of post-transcriptional 
regulation. Precocious expression ofTGase K protein occurs 
in psoriasis, and quantitative Northern blot analysis ofTGase 
K mRNA from normal and involved epidermal biopsies from 
psoriasis patients suggests that TGase K mRNA levels are 
incre~sed in psoriat~c lesions. By using quantitative laser 
scannmg confocallnlcroscopy (LSCM) and in situ hybridiza-
tion, the increase of the TGase K mRNA was in the range of 
3 - 7 times in the psoriatic epidermis and was significantly 
higher compared with normal skin and with paired adjacent 
skin. Quantitative LSCM provides a powerful and direct 
method for analysis of gene expression in skin. ] Invest Der-
matoI99:27-34,1992 
Its transcription is regulated negatively by retinoids and positively 
by Ca++ concentration as described for TGase K activity [6]. 
At least one other trans glutaminase activity has been reported in 
epidermis. This enzyme, TGase E, is soluble, requires proteolytic 
activation, and ap£ears to be distinct from TGase K in physical 
characteristics [7,8 j. Tissue transglutaminases have recently been 
cloned and are expressed in macrophages and endothelial cells 
[9,10]. In this study we describe a partial human cDNA for TGase 
K, which we have established unequivocally as the membrane-
bound enzyme expressed in cultured cells by partial amino acid 
sequencing of the purified protein. W e show that although the 
mRNA is expressed in a tissue-specific pattern, it is unexpectedly 
found throughout normal epidermis rather than at the upper layers 
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of the stratum granulosum as expected by the distribution of the 
protein. Compared with adjacent normal skin and control skin, the 
mRN A is increased in psoriasis lesions. 
MATERIALS AND METHODS 
Isolation and Description ofTGase K cDNA Clones TGase 
K clones were obtained by screening a lambda gt11 expression li-
brary prepared from poly A+ mRNA from keratinocytes cultured in 
1 mM calcium (Clonetech) [11] using a rabbit polyclonal antibody 
raised against purified human TGase K [1 2]. Out of2 X 106 plaques 
screened, seven positives were chosen for further characterization 
by epitope selection [13]. The fusion protein expressed by a cDNA 
clone containing a 0.9-kb imert (pKTG900) bound antibody that 
specifically recognized purified human TGase K by Western blot-
ting [14]. Rescreening with pkTG900 identified cDN A clones with 
Eco Rl inserts of 1.5 kb (pKTG1500) and 0.66 kb (pKTG660), 
which were subcloned into the pGEM-3Z vector (Strategene). 
DNA sequencing [15] on both strands was performed and homol-
ogy with other transglutaminases was found using W ordsearch 
[16]. pKTG 1500 began at the second amino acid G of the ac tive site 
(YGQCWVFA) and contained the pKTG660 clone within the 3' 
sequences. The sequence was deposited in EMBL (accession number 
X57974) and is identical to other published TGase K cDNA se-
quences [17 -20]. pKTG1500 mapped to Chromosome 15 by hy-
bridization to hamster-human hybrid panels, by methods described 
previously [21], confirming the map assignment reported by Pola-
kowlska et al [22]. 
Protein Purification and Sequencing The identity of the 
TGase K clones was established by protein sequencing. TGase K 
was purified by a modification of a monoclonal antibody affinity-
chromatography [23], in which the purified monoclonal antibody 
B.Cl [2] was coupled to N-hydroxysuccinimide biotin (Pierce) and 
attached to avidin-agarose [24]. A non-ionic detergent extract of 
confluent human foreskin' keratinocytes [2] was passed over the 
column and TGase K eluted as described [17]. TGase K was concen-
trated by precipitation in 10% polyethylene glycol (PEG) 6000 
(Sigma), purified on an SDS gel, and cleaved by cyanogen bromide. 
Individual fragments were submitted to Edman degradation on an 
Applied Biosystems 470A gas-phase sequencer following electro-
blotting of SDS-gel-separated bands to an Immobilon PVDF 
membrane [25]. 
Northern Analysis Human keratinocytes, fibroblasts, mela-
noma cells, and A431 squamous carcinoma lines were cultured as 
reported previously [26]. Total mRNA was extracted with guani-
dine isothiocyanate [27] . Shave biopsies taken from established pso-
riasis vulgaris plaques and normal skin within several centimeters 
from the lesions were processed immediately in RNAsol (Biotecx) 
for total RNA extraction [28]. Total RNA was quantitated by UV 
spectroscopy. RNA quality and size was analyzed by ultraviolet 
shadowing [28]. RNA was electrophoresed through agarose for-
maldehyde gels, transferred to Zetabind membranes (Cuno), and 
hybridized to random primer oligo labeled pKTG 1500 insert 
[26,30]. The Northern blots were rehybridized to an oligolabeled 
GAPDH cDNA probe [31] or to an end-labeled 28S RNA oligo 
(Oncogene Sciences) as a standard. The filters were assessed by 
direct counting for 60 min on a Betagen scanner [3~] and by autora-
diography against Kodak XAR 5 film for 1 - 10 d. An RNA ladder 
(Bethesda Research Laboratories) was used as a molecular size stan-
dard. 
Immunofluorescence and Immunoperoxidase Staining 
Fresh frozen tissue sections of normal cheek, forearm, and foreskin 
were incubated with B.Cl monoclonal antibody specific for human 
TGase K and detected using fluorescein-labeled goat anti-mouse 
IgG Qackson Immunolaboratories) as described [2]. Psoriasis lesions 
were stained usin g B.Cl monoclonal detected with biotinylated 
goat-anti mouse and the avidin biotinylated peroxidase complex 
method (Vectastain ABC kit) as described [33J. N egative controls 
were performed with mouse serum and goat anti-mouse IgG 1 
(kindly provided by William Geoghegan) . 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
ATGCCAGTGGCCTACAAGGAATACCGGCCCCATCTTGTGGACCAGGGGGCC 
274 M P V A Y KEY R P H L V D Q G A 
KTG3 P V A Y KEY P L V Q 
ATGCTGCTCAATGTCTCAGGCCACGTCAAGGAGAGCGGGCAGGTGCTGGCC 
292 M L L N V S G H V K E S G Q V L A 
KTG5 L L N V S V K V L A 
Figure 1. Comparison of deduced amino acids with protein sequences. 
Amino acid numbering begins at the first codon of the active site 
(YGQCWVFA). The amino acids (lille 2) deduced from nucleotide se-
quences (lille 1) show good correlation with the sequenced CNBr peptide 
fragments (lille 3) . The N-terminal amino acid sequence ofKTG3 (M Wt. 
21.3 kD) is PVAYKEY-P-LV-Q--M. KTG5 and KTG6 (M Wt 19.6 and 
19.1 kD) gave identical N-terminal sequences: LLNVS--VK----VLA. At 
positions indicated by a dash, the amino acid residue was not clearly identifi-
able. 
In Situ Hybridization The method of in situ hybridization de-
scribed by Stoler et al [34] was used on paraformaldehyde-fixed, 
paraffin-embedded sections from normal human cheek, forearm, 
foreskin, and from psoriasis lesions paired with adjacent skin. In the 
first experiment, normal skin specimens were compared to psoriasis 
lesions from different patients. In the second experiment, psoriasis 
lesions were compared with adjacent normal skin from the same 
1 2 3 4 5 
2.9 kb 
1.3 kb 
Figure 2. Northern blotting shows tissue-specific expression in vitro. 
30 fJ.g per lane of total RNA extracted from cultured A431 sqnamous carci-
noma cells (lalle 1) , human foreskin keratinocytes in 1 mM Ca++ (lalle 2), 
human diaphragm tissue (lalle 3), WM9 melanoma cell line (lalle 4) , and 
cultured human fibroblasts lalle 5) were electrophoresed on formaldehyde 
agarose gels, blotted onto Zetabind membranes, and hybridized with o ligo-
labeled cDNA insert. GAPDH control cDNA probe is shown in the bottom 
pallel. The 2.9-kb mRNA hybridizing to the TGase K cDNA probe was seen 
only in cultured keratinocytes (lalle 2) and was not seen in the other ce lls that 
did express the 1.3-kb GAPDH mRNA band. Markers used were the 1-kb 
ladder (BRL). 
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patient. Sense and antisense riboprobes were used on each biopsy 
specimen. 
Riboprobes were synthesized from linearized pKTG660 using 
th.e Riboprobe Gemini system (Promega) and 35S-labeled uridine 
tnphosphate (Amersham). The pKTG660 3' clone was used be-
cause it lacks the active site that is highly conserved among all 
transglutaminases and gave only one mRNA band on Northern 
blotting. cRNA were then hydrolyzed and hybridized to sections at 
55 a C for 3 h. Following hybridization, sections were washed in 
50% formamide, 2 X SSC for 10 min at 55 a C and again for 20 min 
at 55 a C. Slides were dipped in Kodak NB2 emulsion, developed for 
6 d (experiment 1) or 21 d (experiment 2). Slides were counter-
stamed with Wright's Giemsa. 
I":Iage Analysis Analysis of in situ hybridization was performed 
usmg a Biorad 600 Laser Scanning Confocal Microscope (LSCM) as 
described [35,36]. Briefly, the images were viewed by transmitted 
Itght (tissue section) in parallel with the confocal reflected mode (in 
Situ hybridization signal). The reflected confocal image was visual-
Ized in a 0.5-micron plane within the upper emulsion, representing 
the specific in situ hybridization signal. The transmitted and confo-
cal Images were then merged to localize the signal within areas of 
the skin. 
The digital analysis system integrated with the Biorad LSCM was 
used to quantify intensity of the in situ hybridization signals in 
normal and psoriatic skin biopsies. Hybridization signals repre-
sented by reflected intensity (pixels) within areas ranging from 
15,000 to 25,000 square microns were determined from the confo-
cal on the line image (100 X magnification) from four to six separate 
areas per field in two or three sections from each lesion. The mean 
Intensities in pixels per square micron and standard deviations were 
falcu lated for each area. Intensity readings taken from the upper and 
OWer epidermis of psoriatic lesions were generally similar. Specific 
mean intensities for each lesion were obtained by subtracting the 
sense from the antisense signals. Analysis of variance was used to 
analyze the sampling of individual lesions and the Student-New-
man-Keuls (two-tailed) t test was used to identify statistically signifi-
c.ant differences between individual sense and antisense hybridiza-
tion signals and between psoriasis and paired normal skin [37]. 
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RESULTS 
Nucleotide and Protein Sequences We confirmed our clones' 
identities as TGase K by protein sequence determination. The N-
terminal sequences of three CNBr fragments of TGase K were 
obtained by protein microsequencing at the lowest limit of sensitiv-
ity (10 pmoles/residue or less) and showed excellent correspon-
dence to the predicted amino acid sequence (Fig 1). The CNBr 
fragment KTG3 includes the two smaller fragments sequenced, 
KTG5 and KTG6. The sizes of these fragments as estimated by 
SDS-PAGE [19] were 21.3,19.6, and 19.1 kD. Their relative sizes 
are in agreement with the sizes predicted from the eDNA (17.9, 
16.0, and 15.4 kD). The difference between KTG5 and KTG6 is 
due to partial CNBr cleavage at a methionine close to the C-ter-
minal. This is the first TGase K protein sequence reported. 
Expression of mRNA is Specific for Epidermal Cell In 
Vitro In order to determine the TGase K mRNA size and tissue 
distribution, all three eDNA inserts were hybridized to Northern 
blots containing total mRNA extracted from cultured skin cells (Fig 
2) . All three hybridized to a 2.9-kb mRNA from foreskin keratino-
cytes cultured in 1 mM Ca++ but not in human vulvar squamous 
carcinoma A431 cells, WM9 melanoma cells, cultured human fibro-
blasts, or human diaphragm tissue. 
Expression of Protein in Normal Human Epidermis and 
Psoriasis Keratinocyte transglutaminase protein has previously 
been shown to be present in a narrow distribution in the stratum 
granulosum just under the stratum corneum [23]. In Fig 3A the 
restricted pattern of protein expression as determined by immuno-
fluorescence using the B.Cl mouse monoclonal antibody [17] is 
shown m normal cheek skin, and is representative. No epidermal 
staining was seen using the secondary antibody alone (Fig 3B). It has 
previously been reported that theenzyme becomes active in living 
skm, as demonstrated by Its ability to use dansyl-cadaverine as a 
substrate, in an even more restricted region of the stratum granulo-
sum [38]. 
In wound healing and in psoriasis, we and others have reported 
precocious expression ofTGase K protein throughout the epidermis 
[23,39,40]. As shown in Fig 3C, immunoperoxidase staining of 
c 
p' d~~ure 3. Expression ofTGase K protein in normal skin and psoriasis. A) Immunofluorescence detection ofTGase K with the E.C! monoclonal antibody 
stra:
cted With fluorescein-conjugated goat anti-mouse IgG. There is a narrow band of fluorescence (left) in the upper stratum granulosum just under the spec~rn ~orneum in normal skin specimens studied. (Magnification X 400.) B) Same as specimen A with fluorescein-conjugated goat anti-mouse IgG shows no broa~ c uor.escence. There is co llagen autofluorescence in the dermis (X 400). C) Immunoperoxidase detection of TGase K in psoriatic lesions shows a layers~r distribution than normal skin as represented by the black staining around keratinocytes in the upper epidermis. Protein staining is not seen in the basal 
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Figure 4. Expression ofTGase mRNA by in situ hybridization 
in normal skin. A) Normal human cheek skin with epidermis 
(at left sjde) and hair follicles (righI, arrows) in transmitted mode 
hybridized with antisense TGase K cRNA probe pKTG660. 
(Magnification X 100.) B) Reflected confocal image of section 
A. The specific hybridization overlying the epidermis is more 
clearly revealed in the reflected image as a band of tiny white 
dots and in the dermal hair follicles (X 100). C) Normal human 
check section (A) with sense negative control probe, transmit-
ted image. D) Reflected image of C shows no specific hybridiza-
tion (X 100). E) Transmitted image of human neonatal foreskin 
hybridized with antisense TGase K cRNA probe (X 100). F) 
Reflected image of E shows narrower distribution of the TGase 
K hybridization signal than in section of cheek skin seen in A,B. 
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psoriatic epidermis has a broader distribution than in normal skin, 
but the enzyme does not appear in the basal layer. Secondary anti-
body alone gave no staining (data not shown). It was therefore of 
interest to determine the spatial expression of TGase K mRNA in 
normal human skin and in psoriasis. 
Expression ofTGase K mRNA and Protein is Discordant in 
Normal Skin and Psoriasis Using in situ hybridization we first 
studied the expression ofTGase K mRNA in normal cheek skin (Fig 
4A - D), in neonatal foreskin (Fig 4E,F) , in normal forearm skin 
(not shown), and in psoriasis lesions (Fig 5) and paired normal skin 
samples (not shown). T he sense hybridization signals as negative 
controls are shown in Fig 4C,D and SC,D . The transmitted tissue 
images (4A,C,E) that show the morphology best are compared to 
the reflected signals (4B,D,F) that show the in situ hybridization 
signals as white dots. Specific hybridization due to the antisense 
TGase K probe is shown in Fig 4A,B,D,E. 
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In contrast to the more restricted pattern of immunoflu orescence 
staining for TGase K protein (Fig 3A) [2,5,23,38]' mRNA (as 
judged by in situ hybridization) is observed throughout the epider-
mis in normal skin specimens. Because the normal cheek skin was 
removed adjacent to a basal cel l carcinoma, we were concerned that 
the expression of TGase K might be abnormal, as reported for an-
other differentiation marker, involucrin [41]. However, in other 
specimens of normal sk in examined including two forearms and 
three normal skin biopsies from trunk and extremities within 3 cm 
from psoriatic plagues, a similar distribution was found. The one 
exception noted was the neonatal foreskin (shown in Fig 4E,F), 
where the mRNA appeared to be concentrated more strongly in a 
band- li ke distribution at the upper epidermis as expected by the 
protein distribution. 
Interestingly, given the recent report of keratin 14 expression in 
hair follicles [42], we noted that the expression ofTGase K mRNA 
was most prominent in the outer root sheath areas of follicles 
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Figur~ 5. Expression ofTGase K mRNA in psoriasis lesions by in situ hybridization. A) Psoriasis lesion (lesion 1, Table J) hybridized with antisense cRNA, 
t7nsmItted image (magnification Xl 00) . B) Reflected image oflesion in F shows very intense signal throughout the epidermis (X 100). C) Transmitted image 
o( another section of same psoriasis lesion hybridized with sense TGase cRNA probe (X 100). D) Reflected image of H shows lack of specific hybridization 
>(100). 
Imaged in the upper dermis (Fig 4A,B), but appeared equal in inten-
Sity to the epidermal signal. The other areas of the dermis, exclud-
1i1g hair follicles, were not above background in the hybridization 
signal. 
' . The LSCM digital imaging system allows the confocal reflected 
1i1 Situ colorized image to be superimposed on the transmitted 
Image. This showed that in normal skin sections (forearm and 
cheek), the cells in the basal layer, as well as that in the upper layers, 
contained TGase K mRNA. Therefore, constitutive expression of 
the TGase K message may occur throughout the epidermis without 
translation, and a signal for translation may occur at the level of the 
stratum granulosum. Alternatively, there may be very minute 
amounts of protein made in the basal byers that are not detectable 
using IF or immunoperoxidase methods. 
Table I. Quantitative In Situ Hybridization from Nonnal and Psoriatic Skin Lesions· 
------------________________ 2-______________ ~ __________________________________________________________ _ 
Anti-Sense Sense Anti-Sense - Sense Hybridization Signalb 
Experiment 1 --------~------------------------------------------------------------------------~----~----------Mean SD Mean SD Specific Hybrid 
Normal skin 
1 Ps lesion 
2 Ps lesion 
Experiment 2 
3 Ps normal skin 
3 Ps lesion 
4 Ps normal skin 
4 Ps lesion 
5 Ps normal skin 
5 Ps lesion 
3,4,5 normal skin 
1.38 0.62 
7.73 2.42 
3.88 2.12 
7.28 0.85 
10.48 1.89 
7.88 0.78 
17.83 4.76 
7.04 0.28 
9.52 2.53 
7.40 0.43 
12.61 4.55 
0.23 0.23 1.15 
0.15 0.13 7.58' 
0.03 0.05 3.85' 
5.93 0.24 1.35 
5.91 0.39 4.57J 
7.93 1.27 
-0.05 
7.49 0.89 10.34J 
5.89 0.25 1.15 
5.43 0.27 4.09J 
6.58 1.17 0.82 
6.28 1.08 6.33J _________ 3,4,5 psoriasis 
'p ~----~-------------------------------------------------------------------------------
• 5, pSoriasis. 
Hybridization' 1 d . . . . 1 . f C • fi ld . . b' 
t P < 0 05 . s l~na cxprcssc as mean mtenslty In plxe s per square mJCron rom rour to SIX e S III two or nlore sections per tOpsy. 
J p < O· psor~as~s versus control normal skin . 
. 05 pSonasls versus paired normal skin. 
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Table II. Expression ofTGase K mRNA by Northern Blotting" 
Lane 2 3 4 5 6 7 8 
Source NL PS NL PS NL PS Fibroblasts Keratinocytes 
TGase K 1.6 12.9 3.4 19.0 1.8 25.7 1.7 7.5 
Normalized 4.7 97 37 79 5.9 79 3.6 19 
Increase 20 X 2X 13X 5X 
, The signals of the bands shown in Fig 5 were counted (cpm) and the background signal from the filter was subtracted. The TGase K signal was normalized by dividing by the 28S 
signal and multiplying by 1,000. NL, normal; PS, psoriasis. 
Expression ofTGase K mRNA is Increased in Psoriasis Les-
ions Psoriatic epidermis (Fig SA,B) showed more intense hybrid-
ization compared with normal skin (4A,B) when hybridized in par-
allel under identical conditions. The expression of the mRNA was 
also evident throughout the epidermis, including the basal layer. 
The in situ hybridization signal appears visually more intense per 
unit area in psoriasis than in normal skin. 
To quantitate the intensity of hybridization within a small epi-
dermal unit area, we used the digital image analysis system inte-
grated with the Biorad LSCM. The results of two experiments are 
shown in Table 1. Psoriasis lesions (lesion 1 is shown in Fig 5) were 
compared with normal skin (Fig 4A,B) in experiment 1. In experi-
ment 2, three paired lesions and normal adjacent skin biopsies from 
three additional patients were compared (in situ images not shown) . 
The two experiments cannot be compared with one another because 
different labeling reactions and exposure times were used. How-
ever, in both experiments psoriatic epidermis had 3 - 7 -times greater 
hybridization intensity compared to normal or paired normal skin. 
The differences were statistically significant (Table I). Further-
more, the numbers were consistent over several different fields and 
sections within biopsies, as determined by analysis of variance [30]. 
In order to confirm these findings by a more traditional method, 
quantitative Northern blotting was used to compare paired normal 
and involved skin biopsies from three additional patients with psori-
asis. As shown in Table II, there was a 3 - 20-times greater hybridiza-
tion signal to TGase K in psoriasis skin versus adjacent normal skin. 
By traditional autoradiography, shown in Fig 6, the signal on the 
filter from normal skin is almost undetectable at 20 h exposure (row 
B) but can be visualized if the blot is exposed for 10 d (row A) . The 
psoriasis signals are very intense, even at 20 h, and are overexposed 
at 10 d. Overexposure would prevent accurate quantitation by densi-
tometry but is avoided by direct scanning of radioactive emission 
1 2 345 6 7 8 9 
A 
B 
c 
Figure 6. Quantitative Northern blotting shows increased TGase K 
mRNA in psoriasis lesions. Total RNA (5 Jig/lane) from uninvolved adja-
cent normal skin (fanes 1, 3, and 5), psoriatic plaques (folies 2, 4, and 6), 
cultured fibroblasts lane 7) and keratinocytes (lane 8) was analyzed by 
Northern hybridization to oligo-labeled pKTG660 insert (1 X 109 cpm/ 
Jig). The filter was exposed to Kodak XAR film for 40 h (row B) and for 10 
days (row A), stripped and rehybridized to an end-labeled 40-mer specific for 
28S ribosomal RNA (Oncogene Sciences) (row C). Lalle 9 contains th e RNA 
ladder (BRL) as a marker. TGase K mRNA is 2.9 kb in size between the 4.4-
and 2.3-kb marker bands. Quantitation of the signals shown in this figure arc 
shown in Table II. 
from the filter. The 20-times difference seen between lanes 1 and 2 
(Fig 6) representing psoriasis lesion 4 (Table II) may result from an 
underestimation of the control hybridization signal (row C) used to 
normalize the values. The combination of quantitative in situ hy-
bridization using the LSCM and quantitative Northern blotting 
using a betagen scanner may be useful for studying the regulation of 
other epidermal genes. 
DISCUSSION 
We identified a partial eDNA clone for keratinocyte transgluta-
minase K (TGase K) in order to better understand the regulation of 
this enzyme critical for epidermal differentiation. Because of the 
reported presence of two transglutaminases in epidermis in addition 
to tissue transglutaminase [7 - 10,18]' we confirmed our identifica-
tion of the eDNA clone by protein sequencing of cyanogen bromide 
fragments of membrane-bound TGase K affinity purified by the 
antibody B.C1. The identities of previous clones reported forTGase 
K [6,16 - 20] have been inferred by their homology to other TGase 
and by a pattern of mRNA expression that correlated with that 
reported for membrane-bound TGase K protein. For the first time, 
we provide unequivocal evidence that the reported clones corre-
spond to TGase K. 
An unexpected finding of this study was the distribution of the in 
situ mRNA signal in a pattern that is spatially broader than the 
restricted pattern of protein expression in the stratum granulosum 
previously reported by independent investigators [2,5,23,38]. The 
expression of the TGase K mRNA in the lower levels of the epider-
mis, including basal layers, suggests that the expression of the en-
zyme may be regulated post-transcriptionally. Regional differences 
in the expression of the mRNA may exist, as the pattern in foreskin 
was more restricted than in cheek, forearm, or trunk normal skin. It 
is also possible, however, that the restricted localization of the pro-
tein itself is due to occlusion of the epitope recognized by RCI 
antibody in the lower layers of the epidermis. It is of note that B.Cl 
antibody does react to TGase K even in the absence of calcium. 
Dermal hair fo llicles were also similar in their in situ hybridization 
signal to epidermis but the other parts of the dermis showed hybrid-
ization levels that were not above background. Within hair follicles 
seen in the upper dermis, the TGase K signal was somewhat more 
prominent in the outer root sheath area (Fig 4A,B). 
We have shown by two independent methods that the epidermal 
expression ofTGase K mRNA is increased in psoriasis and demon-
strated that laser scanning confocal microscopy may be a useful tool 
for quantitation of mRNA in skin biopsies. A major disadvantage of 
studying psoriasis biopsies by quantitative Northern blotting is con-
trolling for the amounts of RN A loaded per lane, as well as for the 
proportion of mRNA obtained from epidermis versus dermis from 
shave or punch biopsies [43]. Therefore, one could interpret the 
increased TGase K mRNA found by Northern blots to be due solely 
to the increased proportion of the epidermal component. However, 
when similar unit areas of epidermis were compared for the inten-
sity of in situ hybridization signal, the psoriasis biopsies consistently 
were several times stronger than normal skin, even in paired sam-
ples, and the differences were statistically significant. The use of a 
Betagen scanner also improves the quantitation of Northern blot-
ting, as it provides a direct analysis of the filter without film and 
densitometry [32] . 
TGase K, as a catalyt ic enzyme for cornified envelope formation, 
participates in terminal differentiation of the squamous epithelium 
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[2.6). Calcium (> 1.0 mM) and phorbol esters are agents know n to 
Induce the expression of the enzyme and to induce terminal differ-
entiation [44 ,45) . Retinoic acid, although upregulating tissue 
transglutaminase [46]' inhibits keratinocyte trans glutaminase ex-
pression [6,44,45,47,48J. Transforming growth factor beta 1 upre-
gulates tissue transglutaminase, but has no effect on T Gase K [49]. 
The mechanism of retinoic acid inhibition of the enzyme in culture 
has been suggested to be pre-translational [50] . The discordant ex-
pressIOn of mRNA and protein that we observed has not been de-
scribed in an in vitro system and requires further investigation. 
It IS not yet known w here the primary defect occurs in psorias is: 
whether keratinocytes are intrinsically hyperproliferative and have 
Incr~ased sensitivity to growth fac tors or whether growth factors, 
possIbly T GF-alpha [51 J and interleukin 6 [52]' can induce the 
phenotype. There is growing recognition that the immune system 
and 1l1.f1ammation can play a major role through the generation of 
cytokines [53J. 
Inc.reased expression of TGase K protein and mRNA in psoriasis 
may In part explain the hyperkeratosis characteristic of psoriatic 
lesIons. The formation of a more highly cross-linked stratum cor-
neum may lead to greater retention of the squames observed in 
leslonal skin. It is also possible that retention of the stratum cor-
neum could change the normal regulation of other epidermal genes. 
Alternatively and more likely, increased TGase K expression in 
psonasls may resu lt secondarily from the dysregulation of the nor-
mal epidermal differentiation pathway [39J. Further study of the 
upregulation of T Gase K may contribute to understanding the 
pathogenesis of psoriasis. It is tempting to speculate that one benefi-
cIal effect of retinoids for psorias is may result from their inhibition 
ofTGase K. This hypothesis can be tested experimentally with the 
technIques we have described here. 
We t!' all k Dorothy Lewis, LOllis Smitlr, alld RobertJordoll fo r helpfll l disCIIssioll, Pat 
ShqJield, Willa Collill s, alld Kat lrerine Kelly fo r tecllllica l assistallce, alld Jea t/eue 
~y fo r preparatiot/ of tire mat/ uscript. 
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ANNOUNCEMENT 
The 9th Annual Meeting of the Skin Pharmacology Society will be held October 14-16,1992 
at the Stouffer Tower City Plaza Hotel in Cleveland, Ohio. There will be a special symposium 
on neuroendocrine immunologic interactions in skin, on novel phototherapies, and on clinical 
research, and the Albert Kligman Lecture will be presented October 16. There will be an 
opportunity for free oral and poster communications. The closing date for submission of 
abstracts is May 15, 1992. Abstract forms and meeting registration information can be obtained 
by writing to Pauline M Dowd, MD, FRCP, Secretary jTreasurer-S.P.S., Department of Der-
matology, Middlesex Hospital, Mortimer Street, London W1N 8AA. 
